ClinVar Miner

Submissions for variant NM_032043.2(BRIP1):c.2650T>A (p.Phe884Ile) (rs587780243)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV000116147 SCV000150056 uncertain significance not provided 2014-01-09 criteria provided, single submitter clinical testing This variant is denoted BRIP1 c.2650T>A at the cDNA level, p.Phe884Ile (F884I) at the protein level, and results in the change of a Phenylalanine to an Isoleucine (TTT>ATT). This variant has not, to our knowledge, been published in the literature as pathogenic or benign. BRIP1 Phe884Ile was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. This variant is a conservative substitution of one neutral non-polar amino acid for another, altering a position that is well conserved throughout evolution and is not located in a known functional domain. Multiple in silico algorithms predict that this variant may be damaging to protein structure and function. Based on currently available information, it is unclear whether BRIP1 Phe884Ile is pathogenic or benign. We consider it to be a variant of uncertain significance. Furthermore, BRIP1 has been only recently described in association with cancer predisposition and the risks are not well understood.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.